ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy
Authors:
- 7 September 2022
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 152, 367-379
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81973256, 82173748)
This publication has 34 references indexed in Scilit:
- Cancer-specific chemotherapeutic strategy based on the vitamin K3 mediated ROS regenerative feedback and visualized drug release in vivoBiomaterials, 2018
- Leveraging γ‐Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer CellsAngewandte Chemie International Edition, 2018
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4Nature, 2017
- Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/ChemotherapyNano Letters, 2017
- A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in CancersAdvanced Materials, 2017
- Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formationActa Pharmacologica Sinica, 2017
- Biocompatible Polymeric Nanoparticles Degrade and Release Cargo in Response to Biologically Relevant Levels of Hydrogen PeroxideJournal of the American Chemical Society, 2012
- Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cellsMini-Reviews in Medicinal Chemistry, 2012
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJournal of Controlled Release, 2010
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treatment Reviews, 2009